Manganese superoxide dismutase protects against 6-hydroxydopamine injury in mouse brains

被引:83
作者
Callio, J [1 ]
Oury, TD [1 ]
Chu, CT [1 ]
机构
[1] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15213 USA
关键词
D O I
10.1074/jbc.M413224200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Dopaminergic neurons of the substantia nigra are susceptible to toxin-based insults. Intrastriatal injection of 6-hydroxydopamine results in selective toxicity to these neurons. A mechanistic role for reactive oxygen species is supported by observations that antioxidants confer protection from 6-hydroxydopamine. Although cell culture studies have suggested extracellular or nonmitochondrial mechanisms in 6-hydroxydopamine toxicity, the compartmentalization of oxidative injury mechanisms is incompletely defined in vivo. Transgenic mice overexpressing mitochondrial manganese superoxide dismutase or extracellular superoxide dismutase received unilateral intrastriatal injections of 6-hydroxydopamine. Mice that overexpress manganese superoxide dismutase showed significantly smaller striatal lesions than littermate controls. There were no differences in nonspecific striatal injury associated with contralateral vehicle injection. Manganese superoxide dismutase overexpression also protected against loss of neuronal cell bodies in the substantia nigra. In contrast, mice overexpressing extracellular superoxide dismutase showed no protection from 6-hydroxydopamine toxicity in either brain region. Protection of the nigrostriatal system by overexpression of manganese superoxide dismutase supports a role for mitochondrially derived superoxide in 6-hydroxydopamine toxicity. Mitochondrial oxidative stress appears to be a common mechanism among diverse models of Parkinson disease, whether involving toxins, mutated genes, or cybrid cells containing patient mitochondria. Antioxidant therapies that target this subcellular compartment may prove promising.
引用
收藏
页码:18536 / 18542
页数:7
相关论文
共 94 条
  • [1] Attenuation of 6-hydroxydopamine-induced dopaminergic nigrostriatal lesions in superoxide dismutase transgenic mice
    Asanuma, M
    Hirata, H
    Cadet, JL
    [J]. NEUROSCIENCE, 1998, 85 (03) : 907 - 917
  • [2] Neuronal transfer of the human Cu/Zn superoxide dismutase gene increases the resistance of dopaminergic neurons to 6-hydroxydopamine
    Barkats, M
    Millecamps, S
    Bilang-Bleuel, A
    Mallet, J
    [J]. JOURNAL OF NEUROCHEMISTRY, 2002, 82 (01) : 101 - 109
  • [3] Experimental models of Parkinson's disease
    Beal, MF
    [J]. NATURE REVIEWS NEUROSCIENCE, 2001, 2 (05) : 325 - 332
  • [4] Attenuation of 6-OHDA-induced neurotoxicity in glutathione peroxidase transgenic mice
    Bensadoun, JC
    Mirochnitchenko, O
    Inouye, M
    Aebischer, P
    Zurn, AD
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 1998, 10 (10) : 3231 - 3236
  • [5] THE IRON CHELATOR DESFERRIOXAMINE (DESFERAL) RETARDS 6-HYDROXYDOPAMINE-INDUCED DEGENERATION OF NIGROSTRIATAL DOPAMINE NEURONS
    BENSHACHAR, D
    ESHEL, G
    FINBERG, JPM
    YOUDIM, MBH
    [J]. JOURNAL OF NEUROCHEMISTRY, 1991, 56 (04) : 1441 - 1444
  • [6] Chronic systemic pesticide exposure reproduces features of Parkinson's disease
    Betarbet, R
    Sherer, TB
    MacKenzie, G
    Garcia-Osuna, M
    Panov, AV
    Greenamyre, JT
    [J]. NATURE NEUROSCIENCE, 2000, 3 (12) : 1301 - 1306
  • [7] Betarbet R, 2002, BRAIN PATHOL, V12, P499
  • [8] Extracellular toxicity of 6-hydroxydopamine on PC12 cells
    Blum, D
    Torch, S
    Nissou, MF
    Benabid, AL
    Verna, JM
    [J]. NEUROSCIENCE LETTERS, 2000, 283 (03) : 193 - 196
  • [9] Interaction between 6-hydroxydopamine and transferrin: "Let my iron go''
    Borisenko, GG
    Kagan, VE
    Hsia, CJC
    Schor, NF
    [J]. BIOCHEMISTRY, 2000, 39 (12) : 3392 - 3400
  • [10] Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease
    Cassarino, DS
    Fall, CP
    Swerdlow, RH
    Smith, TS
    Halvorsen, EM
    Miller, SW
    Parks, JP
    Parker, WD
    Bennett, JP
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1997, 1362 (01): : 77 - 86